Coffee chain titan Starbucks (NASDAQ: SBUX) just released a preliminary report for the fourth quarter of 2024. Sales are coming in lower than expected due to fewer (but more profitable) transactions.
Here, we studied the pharmacokinetics, safety, and efficacy of perinatal caffeine administration in near-term lambs following global ischemic injury to support the development of earlier treatment ...